MeSH tree: D12.776.124.790
Federal regulators have granted accelerated approval to a novel therapy for advanced melanoma—giving doctors another weapon to fight this challenging skin cancer.
21 hours ago
0
8
Snakebites aren't random but are predictably correlated with a variety of environmental and socioeconomic factors, according to a study published Aug. 6, 2026, in the journal PLOS Neglected Tropical Diseases by Jaideep Menon ...
Aug 6, 2026
0
10
Mayo Clinic researchers have identified a protein that cancer cells use to shut down the body's immune response, a discovery that could help scientists develop new treatments that make cancer immunotherapies more effective.
Aug 4, 2026
0
197
UCLA researchers have identified a promising strategy to make a new class of targeted cancer therapies more effective against one of the deadliest forms of prostate cancer, potentially overcoming treatment resistance that ...
Aug 4, 2026
0
9
Researchers at the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center are zeroing in on less toxic and more targeted strategies to combat Ewing sarcoma, an aggressive and rare pediatric cancer that develops ...
Aug 4, 2026
0
4
Patients with deficient DNA mismatch repair (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal cancer experienced a 58% reduction in the risk of disease progression or death when treated with atezolizumab ...
Jul 30, 2026
0
7
About a third of children with multiple food allergies gained the ability to safely eat full servings of foods that trigger their allergies in a new Stanford Medicine-led clinical trial. The results were published in JAMA ...
Jul 27, 2026
0
22
Scientists have long sought to understand why some people with no known risk factors develop cancer while others with significant risk never do. The answer may lie in immune proteins known as autoantibodies (auto-Abs), suggests ...
Jul 25, 2026
0
49
Viral infections that attack the lungs are among the leading reasons infants are hospitalized. A new treatment may offer protection against these infections that is as effective and safe as existing options but requires far ...
Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune "brakes" exploited by tumors to evade attack—show limited efficacy in some brain tumors. A KAIST research team ...
Jul 20, 2026
0
15
